OJPed  Vol.3 No.4 , December 2013
Isolated aldosterone deficiency in two infants: Mistakes and dilemmas in the diagnosis and treatment of a rare disease
Abstract: In this article, we describe the clinical picture and follow-up of two children diagnosed as suffering from pseudohypoaldosteronism when they were infants, and it was later recognized as isolated aldosterone deficiency in both. We illustrate the clinical differences between the two patients in terms of hydroelectrolytic balance, laboratory data and growth. In fact, while the growth and hematological parameters of the electrolytes and acid-base balance were normal in the first patient, and also without treatment with fludrocortisone thanks to very high renin activity, in the second patient, this treatment was vitally necessary to maintain normal growth and biochemical data. Despite the absence of a molecular analysis which could have confirmed this diagnosis, we believe that the description of the clinical evolution of these two cases from the moment of the incorrect diagnosis until the correct diagnosis and action taken, could be useful to highlight the extreme clinical variability of this rare disease.
Cite this paper: Pela, I. , Capirchio, L. , Menchini, C. , Anzilotti, G. and Seminara, S. (2013) Isolated aldosterone deficiency in two infants: Mistakes and dilemmas in the diagnosis and treatment of a rare disease. Open Journal of Pediatrics, 3, 391-396. doi: 10.4236/ojped.2013.34071.

[1]   White, P.C. (1994) Disorders of aldosterone biosynthesis and action. New England Journal of Medicine, 331, 250-257.

[2]   Miller, W.L. (2005) The adrenal cortex and its disorders. In: Brook, C., Clayton, P. and Brown, R., Eds., Brook’s Clinical Pediatric Endocrinology, 5th Edition, Blackwell Publishing, Malden, Massachussets, cp. 15, 293-351.

[3]   Kayes-Wandover, K.M., Tannin, G.M., Shulman, D., Peled, D., Jones, K.L., Karaviti, L. and White, P.C. (2001) Congenital hyperreninemic hypoaldosteronism unlinked to the aldosterone synthase (CYP11B2) gene. The Journal of Clinical Endocrinology & Metabolism, 86, 5379-5382.

[4]   Ulick, S., Wang, J.Z. and Morton, D.H. (1992) The biochemical phenotypes of two inborn errors in the biosynthesis of aldosterone. The Journal of Clinical Endocrinology & Metabolism, 74, 1415-1420.

[5]   White, P.C. (2004) Aldosterone synthase deficiency and related disorders. Molecular and Cellular Endocrinology, 217, 81-87.

[6]   Lovas, K., Mc Farlane, I., Nguyen, H.H., Curran, S., Schwabe, J., Halsall, D., Bernhardt, R., Wallace, A.M. and Chatterjee, V.K. (2009) A novel CYP11B2 gene mutation in an Asian family with aldosterone synthase deficiency. The Journal of Clinical Endocrinology & Metabolism, 94, 914-919.

[7]   Choi, M.J. and Ziyadeh, F.N. (2008) The utility of the transtubular potassium gradient in the evaluation of hyperkalemia. Journal of the American Society of Nephrology, 19, 424-426.

[8]   White, P.C. and Bachega, T.A.S.S. (2012) Congenital adrenal hyperplasia due to 21 hydroxylase deficiency: From birth to adulthood. Seminars in Reproductive Medicine, 30, 400-409.

[9]   Saravanapandian, N., Paul, S. and Matthai, J. (2012) Pseudohypoaldosteronism type 1: A rare cause of severe dyselectrolytemia and cardiovascular collapse in neonates. Journal of Clinical Neonatology, 1, 224-226.

[10]   Throckmorton, D.G. and Bia, M.J. (1991) Pseudohypoaldosteronism: Report and discussion of the syndrome. The Yale Journal of Biology and Medicine, 64, 247-254.

[11]   Riepe, F.G. (2013) Pseudohypoaldosteronism. In: Maghnie, M., Loche, S., Cappa, M. Ghizzoni, L. and Lorini, R., Eds., Hormone Resistance and Hypersensitivity. From Genetics to Clinical Management. Endocrine Development, Basel, Karger, 24, 86-95.

[12]   Taymans, S.E., Pack, S., Pak, E., Torpy D.J., Zhuang, Z. and Stratakis, C.A. (1998) Human CYP11B2 (aldosterone synthase) maps to chromosome 8q24.3. The Journal of Clinical Endocrinology & Metabolism, 83, 1033-1036.

[13]   Bassett, M.H., White, P.C. and Rainey, W.E. (2004) The regulation of aldosterone synthase expression. Molecular and Cellular Endocrinology, 217, 67-74. 2003.10.011

[14]   Ulick, S. (1976) Diagnosis and nomenclature of the disorders of the terminal portion of the aldosterone biosynthetic pathway. The Journal of Clinical Endocrinology & Metabolism, 43, 92-96.

[15]   Collinet, E., Pelissier, P., Richard, O., Gay, C., Pugeat, M., Morel, Y. and Stephan, J.L. (2012) Four cases of aldosterone synthase deficiency in childhood. Archives of Pediatrics, 19, 1191-1195.

[16]   Pearse, D.D., Tian, R., Nigro, J., Iorgulescu, J.B., Puzis, L. and Jaimes, E.A. (2008) Angiotensin II increases the expression of the transcription factor ETS-1 in mesangial cells. American Journal of Physiology. Renal Physiology, 294, 1094-1100.

[17]   Mezzano, S.A., Ruiz-Ortega, M. and Egido, J. (2001) Angiotensin II and renal fibrosis. Hypertension, 38, 635-638.

[18]   Jessen, C.L., Christensen, J.H., Birkebaek, N.H. and Ritting, S. (2012) Homozygosity for a mutation in the CYP11B2 gene in an infant with congenital corticosterone methyl oxidase deficiency type II. Acta Paediatrica, 101, 519-525.